Anyway, it's hard to say what would be truly exces
Post# of 148292
Quote:
Anyway, it's hard to say what would be truly excessive depending on IncellDx's growth projections and what they are spending cash on to get to those targets but it is a much bigger number than I would expect. And of course, Cytodyn is on pace to lose $175 million this year so the streets are filled with blood all around.
But which company has massive potential. I'll take 65+ indications over longhauler assays any day.